100%

Executional Excellence

+25 yrs

Experience

3 Countries

BeNeLux

120+

Successful Submissions

Guided Patient Access

Early and Equitable Fast Access programs have been introduced in Belgium.

References

Since January 1, 2026

The initiative aims to provide patients with unmet medical needs quicker access to innovative treatments before or immediately after marketing authorisation. Our dedicated team helps in navigating these pathways to connect patients with life-changing therapies.

Early & Fast Access Program

We are fully engaged with the Early & Fast Access programs, overseen by the CATT/CAIT to bring transformative treatments faster to patients in need, while generating real-world medical and safety data.

Comprehensive Access Solutions

We facilitate a range of early access mechanisms tailored to bring innovation earlier to patients in Belgium.

Named Patient Program

Facilitating access for individual patients and physicians to medicines that are approved in other countries but not yet in Belgium.

Compassionate Use & Medical Need Program

We specialise in designing and implementing compassionate use and medical need programs, compliant with the requirements of the regulatory authorities.

This allows rapid and controlled access to innovative therapies prior to reimbursement.

Value Proposition

Crafting a compelling value story and gathering necessary clinical and economic evidence.

Landscape Assessment

An in-depth analysis of the current landscape, unmet needs, and payer perceptions.

Strategy Development

Defining the optimal pricing, contracting, and access strategy for each target market.

Execution & Launch

Following up on addressing clinical and budgetary uncertainties to maintain patient access.

Integrated Market Access Solutions

A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.

Our Methodology

How We Support Patient Access

Bringing innovative medicines of pharmaceutical and biotech companies to patients, sustainably and meaningfully

Our expertise consists in navigating Pricing & Reimbursement,

Guided Patient Access and Real-World Data

We demonstrate strategic engagement and executional excellence with deep respect for the patient’s voice.

Guided Patient Access

We deliver strategic, landscape-driven access planning that minimises delays and rejections, facilitates early stakeholder dialogue, and embeds patient priorities at the core of your access strategy.

Real World Data

We design and implement Belgium-specific real-world evidence pilots, identifying the right registries and clinical partners while integrating meaningful patient-reported outcomes to strengthen your value proposition.

Pricing & Reimbursement

We build localised value stories, providing end-to-end support from early access to reimbursement.

ABOUT US

SERVICES

HOME

Get in Touch

Whether you have a question about our services, pricing, or need expert strategy consultation, our team is ready to answer all your questions.

Watt The Health, Kliniekstraat 27a

9050 Gent, Belgium

info@axeshealth.com

+32 475 75 26 46

Executional Excellence

Delivering high-quality solutions with precision and reliability

Data Driven

Leveraging Real World Data for impactful decision making.

Partnering for Better Health Access

We bridge the gap between innovation and patient access through strategic pricing, reimbursement expertise, and robust evidence generation.